OncoMed Pharmaceuticals, Inc. (OMED)


Stock Price Forecast

April 11, 2019


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading OncoMed Pharmaceuticals, Inc. chart...

About the Company

Develops anti-cancer stem cell therapeutics

Please visit http://www.oncomed.com for more information about the company.

Exchange

NASDAQ

Website

http://www.oncomed.com

$44M

Total Revenue

None

Employees

$36M

Market Capitalization

-4.57

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $OMED News

Amring Pharmaceuticals Rebrands as Nordic Pharma, Eyes Global Expansion with Strategic Acquisition

5d ago, source: MyChesCo on MSN

BERWYN, PA — Amring Pharmaceuticals Inc. has announced a corporate name change to Nordic Pharma, Inc., marking a new chapter ...

We don't have any news on OncoMed Pharmaceuticals, Inc. at the moment.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...